Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 for Postoperative Pain After Inguinal Herniorrhaphy
NCT02504580Phase 2Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Jul 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc. Started Jul 2015; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02504580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504580.